4
Changes in Ownership
ATOSSA THERAPEUTICS, INC. Filed Acc 0001615774-19-000644
Options or other derivatives
- CFO, Gen Counsel and Secretary acquired 800,000 shares (grant or award)
- CFO, Gen Counsel and Secretary returned 700,000 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Guse Kyle CFO, Gen Counsel and Secretary | 2019-01-13 | Returned to the company · Stock Option (Right to Buy) | −700,000 | 0 | D | ||
| Guse Kyle CFO, Gen Counsel and Secretary | 2019-01-13 | Grant or award · Stock Option (Right to Buy) | +800,000 | 800,000 | D | ||
Loading xslF345X03/s115378_form4.xml…